EULAR: Amputations of body parts: The combination of diabetes and gout significantly increases

August 13, 2020

Diabetes mellitus and gout are ranked among the most common metabolic disorders in Western industrialised countries: According to figures published by the World Health Organization (WHO), around 60 million Europeans suffer from diabetes (2) and 18 million Europeans suffer from gout (3). "Gout is increasingly being linked to unfavourable cardiovascular, renal and metabolic complications, and now amputation risks", says EULAR president Professor Iain B. McInnes from Glasgow, Scotland, Great Britain. In a current study, Brian Lamoreaux, MD, MS from Lake Forest/USA showed how high the risk of amputations of outer limbs is by evaluating 190 million data sets from a patient database.

The research team divided the patients into four groups according to their medical records: patients with gout; patients with diabetes; patient with both gout and diabetes; and patients with neither disease. Afterwards, they compared how many patients from each group required an amputation of the outer limbs. The amputation rate of patients suffering from neither of those diseases was 0.03 percent. By contrast, the amputation rate of patients with gout rose to 0.16 percent. For people suffering only from diabetes, the value trebled to 0.46 percent. "Patients suffering from either gout or diabetes have a significantly increased risk of an amputation. In patients with both diseases, this effect is further amplified", says Dr. LaMoreaux. According to the results of his study, the amputation rate among patients with both diabetes and gout is 0.77 percent, compared to 0.03 percent in the control group.

Professor John Isaacs, Chair of the Scientific Programme Committee of EULAR, emphasises that these results are of highest relevance for daily clinical practice: "The more we know about the risks, complications and complications of diabetes and gout, the more specifically we can inform patients and optimize therapeutic strategies to possibly prevent serious surgeries such as amputations". According to the expert, the loss of a part of the body is particularly hard for many people, furthering the urgency to properly manage both conditions.

1. EULAR Abstract No. 2058: Amputation procedures in patients with gout compared to patients with diabetes, LaMoreaux et al., DOI: 10.1136/annrheumdis-2020-eular.2058

2. WHO Europe: Diabetes - Data and Statistics: (03/07/2020).

3. EULAR: RheumaMap. Research Roadmap to transform the lives of people with Rheumatic and Musculoskeletal Diseases, 2019.

Event information:

EULAR 2020. Online access to scientific contributions will be available until 1 September 2020.

German Society for Rheumatology (DGRh) Congress, 9-12 September 2020 in Munich

EULAR 2021, 02 - 05 June 2021, Paris, France

European League Against Rheumatism

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to